SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001264124-06-000253
Filing Date
2006-05-19
Accepted
2006-05-19 12:07:33
Documents
1
Period of Report
2006-05-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3540
  Complete submission text file 0001264124-06-000253.txt   5388
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Issuer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4560 HORTON STREET M/S R-422 EMERYVILLE CA 94608-2916
Business Address 510-923-2910
BRYSON VAUGHN D (Reporting) CIK: 0001189539 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19700 | Film No.: 06854241